Literature DB >> 25135734

Analysis of Th1/Th2 response pattern for erythrodermic psoriasis.

Ping Zhang1,2, Hong-Xiang Chen1, Yi-Qun Duan2, Wei-Zhen Wang2, Tian-Zhu Zhang2, Jia-Wen Li1, Ya-Ting Tu3.   

Abstract

As one of the most serious types of psoriasis, pathogenesis of erythrodermic psoriasis (EP) is unclear so far. In this study, we aimed to detect the levels of Th1/Th2 cytokine-associated transcription factors and T-lymphocyte clone in peripheral blood mononuclear cells (PBMCs) derived from EP patients, and gene expression level of T-bet/GATA-3 in skin lesion. The potential role of Th1/Th2 reaction pattern played in the pathogenesis of EP was also discussed. Serum levels of IFN-γ, IL-2, IL-4 and IL-10 were quantified by ELISA among 16 EP patients, 20 psoriasis vulgaris (PV) patients and 15 healthy controls. The expression levels of T-bet/GATA-3 in the skin lesion and PBMCs were examined by real-time qPCR. The ratio of Th1/Th2 was measured by flow cytometry. The levels of IFN-γ, IL-2, IL-4 and IL-10 were higher in EP patients than in the healthy controls. The levels of IL-4 and IL-10 were 69.44±11.45 and 12.62±4.57 pg/mL, respectively, in EP patients, significantly higher than those in PV patients and healthy controls (P<0.05). Flow cytometry revealed the levels of both Th1 and Th2 in PBMCs from EP patients were higher than those in healthy controls, and the Th1/Th2 ratio was dramatically lower than in PV patients (P<0.01). The ratios of IFN-γ/IL-4 and T-bet/GATA-3 in EP patients were both less than 1.0, suggesting a reversal when compared with the other two groups. Our study indicated that the EP patients exerted a Th1/Th2 bidirectional response pattern, and the balance of Th cell subsets inclines to Th2, which might be one of the important mechanisms of EP pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25135734     DOI: 10.1007/s11596-014-1322-0

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  20 in total

Review 1.  The immunologic and genetic basis of psoriasis.

Authors:  B J Nickoloff
Journal:  Arch Dermatol       Date:  1999-09

2.  Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines.

Authors:  David J Cousins; Tak H Lee; Dontcho Z Staynov
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

3.  Demonstration and functional analysis of IL-10 receptors in human epidermal cells: decreased expression in psoriatic skin, down-modulation by IL-8, and up-regulation by an antipsoriatic glucocorticosteroid in normal cultured keratinocytes.

Authors:  G Michel; A Mirmohammadsadegh; E Olasz; B Jarzebska-Deussen; A Müschen; L Kemény; H F Abts; T Ruzicka
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

4.  Mutual antagonism of T cells causing psoriasis and atopic eczema.

Authors:  Stefanie Eyerich; Anna T Onken; Stephan Weidinger; Andre Franke; Francesca Nasorri; Davide Pennino; Martine Grosber; Florian Pfab; Carsten B Schmidt-Weber; Martin Mempel; Ruediger Hein; Johannes Ring; Andrea Cavani; Kilian Eyerich
Journal:  N Engl J Med       Date:  2011-07-21       Impact factor: 91.245

5.  IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.

Authors:  K Asadullah; W Sterry; K Stephanek; D Jasulaitis; M Leupold; H Audring; H D Volk; W D Döcke
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

6.  Th2 Cytokines and Atopic Dermatitis.

Authors:  Eric B Brandt; Umasundari Sivaprasad
Journal:  J Clin Cell Immunol       Date:  2011-08-10

7.  Polyclonal and allergen-induced cytokine responses in adults with asthma: resolution of asthma is associated with normalization of IFN-gamma responses.

Authors:  Joanne M Smart; Elisabeth Horak; Andrew S Kemp; Colin F Robertson; Mimi L K Tang
Journal:  J Allergy Clin Immunol       Date:  2002-09       Impact factor: 10.793

8.  Differential expression of mRNA for Th1 and Th2 cytokine-associated transcription factors and suppressors of cytokine signalling in peripheral blood mononuclear cells of patients with atopic dermatitis.

Authors:  S Arakawa; Y Hatano; K Katagiri
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

9.  Serum interferon-gamma is a psoriasis severity and prognostic marker.

Authors:  Marwa A Abdallah; Mahmoud F Abdel-Hamid; Amr M Kotb; Elham A Mabrouk
Journal:  Cutis       Date:  2009-09

10.  Interleukin 4 plasma levels in psoriasis vulgaris patients.

Authors:  Anna Zalewska; Janina Wyczółkowska; Bozena Dziankowska-Bartkowiak; Anna Sysa-Jedrzejowska
Journal:  Med Sci Monit       Date:  2004-04
View more
  14 in total

1.  Clinical analysis of 84 cases of erythrodermic psoriasis and 121 cases of other types of erythroderma from 2010-2015.

Authors:  Ping Zhang; Hong-Xiang Chen; Jian-Jun Xing; Zhao Jin; Feng Hu; Teng-Long Li; Xiao-Yong Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

2.  Two cases of Erythrodermic psoriasis treated with Golimumab.

Authors:  Mayssoun Kudsi; Mhd Amin Alzabibi; Mosa Shibani
Journal:  Ann Med Surg (Lond)       Date:  2022-06-08

3.  Erythrodermic Psoriasis Following SARS-CoV-2 Infection.

Authors:  A Fatima-Zahra; G Basri; S Nejjari; S Chiheb
Journal:  Actas Dermosifiliogr       Date:  2022-07-20

Review 4.  The Inflammatory Response in Psoriasis: a Comprehensive Review.

Authors:  Yaxiong Deng; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

Review 5.  Targeted Treatment for Erythrodermic Psoriasis: Rationale and Recent Advances.

Authors:  Shuai Shao; Gang Wang; Emanual Maverakis; Johann E Gudjonsson
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

6.  Clinical Features and Genetic Polymorphism in Chinese Patients with Erythrodermic Psoriasis in a Single Dermatologic Clinic.

Authors:  Yang Lo; Hsien-Yi Chiu; Tsen-Fang Tsai
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

Review 7.  Generalized erythrodermic psoriasis triggered by vaccination against severe acute respiratory syndrome Coronavirus 2.

Authors:  Tong Ba Tran; Nhi Thi Uyen Pham; Huy Ngoc Phan; Hao Trong Nguyen
Journal:  Dermatol Ther       Date:  2022-03-27       Impact factor: 3.858

8.  Integrated computational approach to the analysis of RNA-seq data reveals new transcriptional regulators of psoriasis.

Authors:  Alena Zolotarenko; Evgeny Chekalin; Alexandre Mesentsev; Ludmila Kiseleva; Elena Gribanova; Rohini Mehta; Ancha Baranova; Tatiana V Tatarinova; Eleonora S Piruzian; Sergey Bruskin
Journal:  Exp Mol Med       Date:  2016-11-04       Impact factor: 8.718

Review 9.  The Immunogenetics of Psoriasis and Implications for Drug Repositioning.

Authors:  Xuan Xu; Hong-Yu Zhang
Journal:  Int J Mol Sci       Date:  2017-12-08       Impact factor: 5.923

10.  Erythrodermic psoriasis: pathophysiology and current treatment perspectives.

Authors:  Rasnik K Singh; Kristina M Lee; Derya Ucmak; Merrick Brodsky; Zaza Atanelov; Benjamin Farahnik; Michael Abrouk; Mio Nakamura; Tian Hao Zhu; Wilson Liao
Journal:  Psoriasis (Auckl)       Date:  2016-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.